Influence of pyrazofurin on the toxicity and antitumor activity of fluorinated pyrimidines in vivo.
D000577:Amides; D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use* / Q000633:toxicity; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use* / Q000633:toxicity; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011720:Pyrazoles; D012263:Ribonucleosides / Q000627:therapeutic use*; D012266:Ribose; D014529:Uridine / Q000031:analogs & derivatives* / Q000627:therapeutic use / Q000633:toxicity
D000577:Amides; D000964:Antimetabolites, Antineoplastic; D011720:Pyrazoles; D012263:Ribonucleosides; C002997:pyrazofurin; C001943:5-fluorouridine; D012266:Ribose; D005472:Fluorouracil; D014529:Uridine